NEUROSTEROIDS, VIA SIGMA-RECEPTORS, MODULATE THE [H-3] NOREPINEPHRINERELEASE EVOKED BY N-METHYL-D-ASPARTATE IN THE RAT HIPPOCAMPUS

Citation
Fp. Monnet et al., NEUROSTEROIDS, VIA SIGMA-RECEPTORS, MODULATE THE [H-3] NOREPINEPHRINERELEASE EVOKED BY N-METHYL-D-ASPARTATE IN THE RAT HIPPOCAMPUS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(9), 1995, pp. 3774-3778
Citations number
52
Categorie Soggetti
Multidisciplinary Sciences
ISSN journal
00278424
Volume
92
Issue
9
Year of publication
1995
Pages
3774 - 3778
Database
ISI
SICI code
0027-8424(1995)92:9<3774:NVSMT[>2.0.ZU;2-K
Abstract
N-Methyl-D-aspartate (NMDA, 200 mu M) evokes the release of [H-3]norep inephrine ([H-3]NE) from preloaded hippocampal slices. This effect is potentiated by dehydroepiandrosterone sulfate (DHEA S), whereas it is inhibited by pregnenolone sulfate (PREG S) and the high-affinity sigma inverse agonist 1,3-di(2-tolyl)guanidine, at concentrations of greate r than or equal to 100 nM. Neither 3 alpha-hydroxy-5 alpha-pregnan-20- one nor its sulfate ester modified NMDA-evoked [H-3] NE overflow. The a antagonists haloperidol and [2-(3,4-dichlorophenyl)-ethyl]-4-methylp iperazine, although inactive by themselves, completely prevented the e ffects of DHEA S, PREG S, and 1,3-di(2-tolyl)guanidine on NMDA-evoked [3H]NE release. Progesterone (100 nM) mimicked the antagonistic effect of haloperidol and -[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine. These results indicate that the tested steroid sulfate esters differe ntially affected the MMDA response in vitro and suggest that DHEA S ac ts as a sigma agonist, that PREG S acts as a sigma inverse agonist, an d that progesterone may act as a sigma antagonist. Pertussis toxin, wh ich inactivates the G(i/o) types of guanine nucleotide-binding protein (G(i/o) protein) function, suppresses both effects of DHEA S and PREG S. Since sigma(1) but not sigma(2) receptors are coupled to G(i/o) pr oteins, the present results suggest that DHEA S and PREG S control the NMDA response via sigma(1) receptors.